PT Hetzer Medical Indonesia Tbk

PT Hetzer Medical Indonesia Tbk

MEDS.JK
PT Hetzer Medical Indonesia TbkID flagIndonesia Stock Exchange
85.00
IDR
-1.00
- -
132.81BMarket Cap
PT Hetzer Medical Indonesia Tbk
MEDS.JK
(Indonesia Stock Exchange)

Recent

price

85.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
PT Hetzer Medical Indonesia Tbk (MEDS.JK) manufactures and distributes medical devices under the Evo Plusmed brand, specializing in innovative 4D-designed masks, diagnostic instruments, and personal protective equipment primarily in Indonesia. The company produces a range of surgical and daily-use masks including Evo Plusmed 4D Sparks 4 Ply, 4D Colorful 3 Ply, 4D White 3 Ply, 4D Pon 4 Ply, 4D 5 Ply, 4D Hijab 3 Ply, and Evo Mask for Kids; sphygmomanometers such as Evo Plusmed Quantum Wall Aneroid, Quantum Mobile Aneroid, Quantum Desk Aneroid, and Colorful Aneroid; stethoscopes comprising Evo Plusmed Cardiology, Classic, Stylo, and Colorful models; bouffant caps; and antiseptic hand rubs. Founded in 2010 and headquartered in Cimahi, West Java, at Kompleks Blue Sky Industrial (BSI) Kav. N, the company operates a manufacturing facility on-site, employs approximately 16-18 people, and holds distribution permits from Indonesia's Ministry of Health for its premium-quality products made from high-grade, environmentally friendly materials. Recent developments include a significant shareholding increase by Jemmy Kurniawan to 60% in January 2025, amendments to its articles of association for expanded business activities, authorized capital, and paid-up capital from IDR 250 million to IDR 4.84 billion as approved by the Minister of Law and Human Rights, alongside revenue growth to IDR 6.39 billion in 2024 despite ongoing net losses.